Geriatrics

How improved telemedicine options could benefit the geriatric patient population and others who may not actually be suitable for emergency care situations.

A recent analysis of the IMPROVE-IT results found that simvastatin-ezetimibe was associated with greater reductions in LDL-C and lower rates of MI, stroke and CVD than simvastatin monotherapy.

Leading a healthy lifestyle can decrease a person's risk of dementia, even if a patient already has a high genetic risk, according to a new study.

Analysis of 2 phase 3 trials found that 24% of patients experienced new choroidal neovascularization over the course of the 96-week trials.

Investigators from the University of Pennsylvania found that rates of those using an advanced practitioner for primary care appointments nearly doubled between 2012 and 2016.

An assessment of programs designed to increase patient physical activity found additional benefits for patients' long-term health outcomes.

What is the role of a primary care physician in treating later-onset multiple sclerosis?

After examining a cohort of 14,599 people, investigators found that meeting minimum physical activity guidelines could prevent 46% of deaths at population level.

A recent study found that initiation of dialysis was associated with a decline in functional status and a rise in caregiver burden.

How advanced biologic care and symptom management programs fail patients more advanced in their disease.

The first-approved therapy for what clinicians once called the 'chronic' form of multiple sclerosis has changed standards of care.

Investigators examined anti-VEGF injections claims data among Medicare Part B beneficiaries from 2012 to 2015 and found that aflibercept injections increased by 69% during that time.

A recent study reviewed operating times of ophthalmic procedures before and after transition to a new EHR system in 2 outpatient departments and an ambulatory surgical center.

A study presented at ADA 2019 examined the efficacy of sitagliptin compared with dapagliflozin in t2d patients 65 years old and older.

A three-arm clinical trial of the SAMBA program showed that screening for and tailoring to individuals' asthma needs improves their condition management.

Ranibizumab was approved for AMD treatment in Korea in 2007, but most supporting trials had been conducted among Caucasian patients.

A review highlights aflibercept’s efficacy in treatment non-responders and points to a couple promising new AMD therapies in development.

Metformin use associated with a 58% reduced risk of age-related macular degeneration (AMD) in a case-controlled retrospective study.

The field has a growing demand of care, and dropping rate of new specialists. The solution can start at medical schools.

Jason Hsu, MD, and his colleagues at the Wills Eye Hospital presented a study at ARVO 2019 regarding short-term outcomes of patients, with nAMD, who switched from afliberecept to ranibizumab.

Investigators examined more than 600 fellow eyes in a secondary analysis to identify 2 imaging features and 1 genetic variant linked to conversion.

In a 15-year study, investigators found that moderate consumption of eggs can significantly reduce a patient’s risk of developing incident, late-stage age related-macular degeneration

After a Mendelian analysis, investigators found that the genetic variants examined explained 4.4% of the variance in refractive error in their patient sample.

The humanized single-chain antibody fragment could become the first of its kind approved for the common eye condition.

Study finds that patients who received as-needed injections saw a significant anatomical and functional improvement.